Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 2Sarcoma 2Head & Neck 2Other solid neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Parathyroid Diseases 1Neoplasms 1Margins of Excision 1Head and Neck Neoplasms 1Adenoma 1

Interventions

Cisplatin 89pembrolizumab 83Magnetic Resonance Spectroscopy 47Radiotherapy, Intensity-Modulated 41Specimen Handling 37Cetuximab 37Carboplatin 37Radiotherapy 36Nivolumab 29Paclitaxel 25Platinum 23Radiation 22Docetaxel 22Gemcitabine 21Biopsy 211,2-diaminocyclohexaneplatinum II citrate 21Surveys and Questionnaires 17Fluorouracil 14toripalimab 13Standard of Care 13Taxes 11Cyclophosphamide 10cemiplimab 9atezolizumab 9X-Rays 9Surgical Procedures, Operative 9Ipilimumab 9Immunoglobulin G 9Drug Therapy 9Capecitabine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Indocyanine Green × Head & Neck × 90 days × Clear all
NCT07149207 2026-05-12

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Medical University of South Carolina

Phase 2 Recruiting
30 enrolled
Head & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT06169735 2026-05-06

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

University of Alabama at Birmingham

Phase 4 Terminated
417 enrolled
Head & Neck

Adenoma, Parathyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡